Authorities in the US state of Utah have granted regulatory approval to the company Nola Health to deliver comprehensive dermatological consultations powered by artificial intelligence, enabling the automated treatment of acne without the necessity of direct human intervention. This innovative digital service operates by conducting a smart scan of the patient's face, followed by an accurate analysis of the skin condition to formulate a tailored treatment regimen adhering strictly to predefined clinical protocols approved by certified physicians. The implementation falls within a broader movement aimed at integrating intelligent technologies into modern healthcare, while embedding safety mechanisms to effectively handle conditions that cannot be decisively determined by algorithms alone. According to a report published by Digital Trends, whenever the automated system encounters ambiguity regarding a specific diagnosis, the case is immediately referred to human medical specialists to ensure a thorough professional evaluation. Nola Health specifically selected acne management as its initial offering due to its status as a low-risk dermatological condition that can be systematically managed through validated and standardized medical workflows, while keeping complex cases under clinical oversight. Utah's landmark decision establishes a pioneering healthcare model that harmonizes artificial intelligence capabilities with verified medical guidelines, retaining essential human intervention when necessary. This significant step represents an impactful experiment in healthcare technology, carrying far-reaching implications that could fundamentally reshape future access to specialized dermatological care across diverse regions worldwide.